Google
NSRX — NASUS PHARMA LTD. (Healthcare >> Drug Manufacturers - General)
NSRX FAQ
What is NSRX's ROE?
NASUS PHARMA LTD. reports a Return on Equity (ROE) of -211.56%.
What is NSRX's dividend yield?
NASUS PHARMA LTD. offers a dividend yield of 0.00%.
What is NSRX's Deepscope Quality Score?
Deepscope rates NSRX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NSRX?
Deepscope's AI Timing Score for NSRX is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NSRX belong to?
NASUS PHARMA LTD. is classified under the Healthcare >> Drug Manufacturers - General sector on the NYSE MKT exchange.
|
USD 2.93
Price
-0.31
(-9.57%)
Day Change
|
|
|---|
NSRX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
36% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.93 |
| PBV / Sector |
9.54 / 2.84
|
| Earning Per Share | -0.65 |
| PE / Sector |
N/A / 24.53
|
| PEG or PE/Growth / Sector |
N/A / 0.08
|
| Average 1M Daily Value |
0.15 M
GREAT
|
| Average 1W Daily Value |
0.15 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
37% |
| Lợi tức cho nhà đầu tư |
|
8% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:08:51 |
| Symbol | NSRX |
| Name | NASUS PHARMA LTD. |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NYSE MKT |
| Listed Shares | 11.71 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 26.42 / 241,254.65 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Yigal Alon 65, Tel Aviv, Israel, 6744317
Phone: 972 3 573 6632
Website: https://www.nasuspharma.com
Description: Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
